Sector ratings Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 23:00:03 15/07/2026 +03			5-day change	1st Jan Change
228.22 ^USD	-1.29%		+1.90%	+14.41%

07-13	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT
07-13	Baird Adjusts Charles River Laboratories International Price Target to $255 From $213, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	11.14B		AA
LONZA GROUP AG	50.35B		AAA
REVOLUTION MEDICINES, INC.	39.32B	-	B	-	-
IQVIA HOLDINGS INC.	34.69B		AAA
BEONE MEDICINES AG	34.08B		-
CELLTRION, INC.	26.63B		A
ASCENDIS PHARMA A/S	16.49B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.31B		BBB
EUROFINS SCIENTIFIC SE	13.8B		AA
ICON PUBLIC LIMITED COMPANY	12.87B		AAA
ABIVAX	11.71B	-	BBB	-	-
BIO-TECHNE CORPORATION	11.1B		AA
TEMPUS AI, INC.	10.54B		A		-
APOGEE THERAPEUTICS, INC.	10.04B	-	B	-	-
IONIS PHARMACEUTICALS, INC.	9.08B	-	A	-	-
KYMERA THERAPEUTICS, INC.	9.22B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	9.14B	-	B	-	-
ALKERMES PLC	8.6B		A
QIAGEN N.V.	8.59B		AAA
PHARMARON BEIJING CO., LTD.	9.14B		AA
Average	17.59B		A
Weighted average by Cap.			A